Insider Selling: SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells $51,013.00 in Stock

SI-BONE, Inc. (NASDAQ:SIBN) insider Anthony J. Recupero sold 3,670 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $13.90, for a total value of $51,013.00. Following the completion of the sale, the insider now directly owns 222,814 shares in the company, valued at approximately $3,097,114.60. This represents a 1.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

SI-BONE Trading Up 1.8 %

SI-BONE stock opened at $14.40 on Thursday. The business has a 50 day moving average price of $13.66 and a two-hundred day moving average price of $14.17. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. SI-BONE, Inc. has a 12 month low of $11.70 and a 12 month high of $21.64. The stock has a market cap of $603.91 million, a price-to-earnings ratio of -15.65 and a beta of 1.16.

Wall Street Analyst Weigh In

A number of research firms have issued reports on SIBN. Truist Financial raised their target price on SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. Needham & Company LLC restated a “buy” rating and issued a $19.00 price objective on shares of SI-BONE in a research note on Wednesday, November 20th. Six analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $23.00.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Jane Street Group LLC increased its holdings in SI-BONE by 29.0% in the 3rd quarter. Jane Street Group LLC now owns 77,359 shares of the company’s stock valued at $1,081,000 after buying an additional 17,410 shares during the period. Millrace Asset Group Inc. bought a new stake in SI-BONE in the third quarter valued at about $1,056,000. Champlain Investment Partners LLC increased its stake in SI-BONE by 14.7% in the third quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company’s stock valued at $39,145,000 after acquiring an additional 358,821 shares during the period. Impax Asset Management Group plc raised its position in SI-BONE by 41.3% in the third quarter. Impax Asset Management Group plc now owns 758,521 shares of the company’s stock worth $10,604,000 after purchasing an additional 221,604 shares in the last quarter. Finally, American Century Companies Inc. lifted its stake in SI-BONE by 22.8% during the second quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock worth $25,685,000 after purchasing an additional 368,637 shares during the period. 98.11% of the stock is currently owned by institutional investors and hedge funds.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.